{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.048935","value":"0.00482"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"206"}],"units":"Participants"}],"title":"C1 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.385958","value":"0.50257"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"}],"units":"Participants"}],"title":"C1 D1, EOI"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.308119","value":"0.52993"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"105"}],"units":"Participants"}],"title":"C1 D1, SOI + 2 hours"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.944185","value":"1.24435"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"}],"units":"Participants"}],"title":"C1 D2, SOI + 24 hours"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.499179","value":"0.75975"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"113"}],"units":"Participants"}],"title":"C1 D4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.163228","value":"0.16905"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"119"}],"units":"Participants"}],"title":"C1 D8-15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.011322","value":"0.00236"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"}],"units":"Participants"}],"title":"C1 D22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.372987","value":"0.27226"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"title":"C2 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.025276","value":"0.00314"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"189"}],"units":"Participants"}],"title":"C2 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.431549","value":"0.52055"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"186"}],"units":"Participants"}],"title":"C2 D1, EOI"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.283128","value":"0.24057"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"}],"units":"Participants"}],"title":"C3 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.091695","value":"0.01507"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"149"}],"units":"Participants"}],"title":"C3 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.396744","value":"0.50649"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"148"}],"units":"Participants"}],"title":"C3 D1, EOI"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.338394","value":"0.50982"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"}],"units":"Participants"}],"title":"C3 D1, SOI+ 2 hours"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.552990","value":"0.61414"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"}],"units":"Participants"}],"title":"C3 D2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.477242","value":"0.80486"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"125"}],"units":"Participants"}],"title":"C3 D2, SOI + 24 hours"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.279372","value":"0.55168"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"71"}],"units":"Participants"}],"title":"C3 D4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.109425","value":"0.15658"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"}],"units":"Participants"}],"title":"C3 D8-15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"C3 D22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.676984","value":"0.44550"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"title":"C4 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.046683","value":"0.01072"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"124"}],"units":"Participants"}],"title":"C4 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.313553","value":"0.48903"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"122"}],"units":"Participants"}],"title":"C4 D1, EOI"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.222222","value":"0.20500"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"C6 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.011594","value":"0.00247"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"90"}],"units":"Participants"}],"title":"C6 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.272831","value":"0.44992"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"90"}],"units":"Participants"}],"title":"C6 D1, EOI"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.258333","value":"0.08611"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"C9 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.289200","value":"0.04322"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"}],"units":"Participants"}],"title":"C9 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"}],"units":"Participants"}],"title":"C12 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.080759","value":"0.01859"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"}],"units":"Participants"}],"title":"C12 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.000000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"C18 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.025477","value":"0.00884"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"title":"C18 D1, Pre-dose"},{"categories":[{"measurements":[{"comment":"Standard Deviation is not evaluable for a single participant.","groupId":"OG000","spread":"NA","value":"0.000000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"C24 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"C24 D1, Pre-dose"},{"categories":[{"measurements":[{"comment":"Standard Deviation is not evaluable for a single participant.","groupId":"OG000","spread":"NA","value":"0.000000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"C30 D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"title":"C30 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"title":"C36 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.00000","value":"0.00000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"C42 D1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.114319","value":"0.03551"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"128"}],"units":"Participants"}],"title":"EOT (~242 weeks)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"217"}],"units":"Participants"}],"description":"Blood samples were collected at indicated time points for pharmacokinetic analysis of belantamab mafodotin","dispersionType":"Standard Deviation","groups":[{"description":"Participants with relapsed/refractory multiple myeloma (RRMM) received 30 minutes intravenous infusion of 2.5 milligram/kilogram (mg/kg) belantamab mafodotin on day 1 of each 21-day cycle","id":"OG000","title":"Belantamab Mafodotin"}],"paramType":"MEAN","populationDescription":"Pharmacokinetic population. Only those participants who were measured and analyzed (i.e., contributed data reported in the table) were included in the Overall Number of Participants Analyzed field. 'Number Analyzed' signifies participants evaluable for the specified time points.","reportingStatus":"POSTED","timeFrame":"Pre-dose on Day (D)1 of Cycles (C)1,2,3,4,6,9,12,18,24,30,36,42; EOI on D1 of C1,2,3, 4 & 6; D1 SOI + 2 h of C1&3; D2 SOI + 24h of C1&3; D4, D8-15, D22 of C1&3; D1 of C2,3,4,6,9,12,18,24 & 30; D2 of C3; and EOT (~242 weeks)","title":"Observed Plasma Concentrations of Belantamab Mafodotin-Cys-mc Microtubular Inhibitor Monomethyl Auristatin-F (MMAF)","type":"SECONDARY","unitOfMeasure":"ug/mL"}